The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 2014 ACR/ARHP Annual Meeting: Bone Fracture Concerns in Children

2014 ACR/ARHP Annual Meeting: Bone Fracture Concerns in Children

April 1, 2015 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

You Might Also Like
  • 2014 ACR/ARHP Annual Meeting: Rheumatologic Research Uncovers Clues to Therapies
  • Bone Density Concerns: Guidance on Tackling Fracture Risk in CKD
  • ACR/ARHP Annual Meeting 2012: New Treatments and Strategies Emerge for Osteoporosis
Explore This Issue
April 2015
Also By This Author
  • Tips for Interdisciplinary Pain Management in Older Patients
Children and adolescents with pediatric rheumatic diseases may be at increased risk for fractures.
Image Credit: ChameleonsEye/shutterstock.com
Children and adolescents with pediatric rheumatic diseases may be at increased risk for fractures.

BOSTON—Children and adolescents with pediatric rheumatic diseases may be at increased risk for fractures and low bone-mass density, and rheumatologists should watch for signs of broken bones even in asymptomatic patients, an expert on pediatric rheumatic disease treatment told attendees at the ACR/ARHP Annual Meeting in Boston on Nov. 18, 2014.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Speaking on, Protecting Bone Health in Pediatric Rheumatic Diseases, Jon “Sandy” Burnham, MD, MSCE, clinical director of the Division of Rheumatology at the Children’s Hospital of Philadelphia, explored how bones develop and where problems may occur in kids in this patient population. Rheumatologists treating pediatric patients should appreciate the contributions of inflammation, glucocorticoid therapy and an altered body composition to lower bone mass and elevated fracture risk in this population, he said.

Careful monitoring, DXA and other imaging techniques, and bisphosphonates may help some pediatric rheumatic disease patients reduce fracture risk, Dr. Burnham said. Bisphosphonates are not FDA approved for use in pediatric patients, he noted.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Burnham
Dr. Burnham

Dr. Burnham began with the “cautionary tale” of one of his juvenile dermatomyositis patients, a 7-year-old girl who developed severe pain in her back and thigh two months after improving on her initial combination therapy, which included DMARDs and glucocorticoids. An MRI scan of her back revealed epidural lipomatosis and several vertebral compression fractures. Her steroids were tapered, and she was offered bisphosphonates, although her family initially rejected this treatment option, Dr. Burnham said.

 

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Very Strong Structures

“Bones serve a variety of functions,” said Dr. Burnham. They are a bank for minerals, protect our internal organs and support our bodies’ movements with the minimum possible mass. “They are very strong structures. Even with the stupid risk-taking behaviors we all do as children, they really should not break.” Although most kids with rheumatic diseases will not experience a fracture, rheumatologists should watch for vertebral compression fractures even in patients who are asymptomatic, he said.

Several factors contribute to normal growth and skeletal development during childhood. Important bone boosters include normal nutrition, with recommended levels of vitamin D and calcium, and weight-bearing physical activity. “Bone adapts mechanical forces to maintain strain at a constant set point,” he said. Osteocytes sense the strain of activities and send effector signals that lead to the production of osteoblasts and osteoclasts, which regulate bone modeling.

Pediatric rheumatic disease patients face some unique challenges to healthy bone development, said Dr. Burnham.

“Pubertal delay is an important factor in peak bone mass. The later the onset of puberty, the lower your peak bone mass,” said Dr. Burnham. Glucocorticoid therapy may also reduce their sex steroids, muscle mass and calcium absorption, all contributing to lower bone mass. In these chronically ill patients, osteoclast development increases under the influence of RANK ligand, increasing bone resorption. They may have less osteoblast formation and lower bone formation, he said. “All of these factors converge to create lower bone mass and increased risk of fracture during childhood.” After skeletal maturation, when bone mass begins to decline, adult patients with a history of rheumatic disease during childhood may “reach the fracture threshold earlier than a person with relative health would,” Dr. Burnham said.

Dual-energy X-ray absorptiometry (DEXA) imaging helps rheumatologists assess bone mineral content and areal bone mineral density (BMD). Consider DEXA testing after a patient has taken six to 12 months of glucocorticoids, Dr. Burnham said.

Scores are strongly correlated with the patient’s height, Dr. Burnham said. “Patients with short stature will have a lower area BMD, even if their bones have normal volumetric density.” DEXA Z-scores may be adjusted at least for sex and age, and ideally, for race or other factors that may affect bone density. Z-score calculations that mitigate height bias can now be calculated on the Bone Mineral Density in Childhood Study website (http://www.bmdcspublic.com), he said.

A diagnosis of osteoporosis in a pediatric patient should not be made on the basis of densitometric criteria alone, Dr. Burnham said. A patient should have experienced one or more vertebral compression fractures in the absence of local disease or trauma. Alternatively, a patient should have two or more long bone fractures by age 10, three or more long bone fractures at any age up to 19, or a BMC or a BMD Z-score of less than or equal to -2.

JIA patients face unique risks, he said. “Kids with JIA will all have the same bone risk factors as healthy kids,” including age, gender, nutritional status, intrauterine environment, genetic load, geography and risk-taking behaviors. “But JIA results in impaired cortical and trabecular bone accrual,” possibly due to medications, disease activity and lower muscle mass. They may be at greater risk for falls because of altered balance or muscle weakness, and face higher fracture risks in their arms and legs. If they have one fracture, they have an increased risk of another fracture later on, said Dr. Burnham.

Patients with pediatric systemic lupus erythematosus (SLE) also face a higher incidence of vertebral fracture risk, he said. In one study of 68 pediatric SLE patients, 56% of the participants had low or low normal spine areal BMD three years after diagnosis.

“Things don’t really get better after diagnosis in pediatric lupus,” he said. Cumulative effects of prednisone may lead to poor lumbar vertebral and trabecular strength. “It also seemed like the biggest decreases in bone mass were in those who developed lupus after puberty. Maybe these patients do not have as much potential to recover from initial losses experienced when disease activity and glucocorticoid therapy were maximal.”

Intervention Strategies

What can rheumatologists do to help young patients increase bone strength? Evidence does not support a strong endorsement for calcium supplementation in this population. Effects may be limited and not long lasting, he said. He recommends adequate calcium in his patients’ diet instead. Rheumatologists may supplement vitamin D, which is deficient in many pediatric lupus patients. The Endocrine Society guidelines recommend between 600 and 1,000 IU per day for an at-risk pediatric patient, with an upper limit of 4,000 IU per day to maintain a 25-hydroxyvitamin D level greater than 30 nanograms per milliliter.

Bisphosphonates, which are not FDA approved for pediatric patients, may help inhibit osteoclast function and bone resorption, but don’t hinder bone formation, Dr. Burnham said. Plan ahead for infusing these patients by checking serum creatinine, calcium and biomarkers of bone metabolism. Ensure that these patients do not need major dental work after infusion begins, and wait at least three weeks after invasive dental work to begin infusions, he said.

Most pediatric rheumatic disease patients will not have a fracture, but it’s important to have a strategy to lower their risk, Dr. Burnham said. Use steroid-sparing agents when possible. Maintain vitamin D levels, ensure dietary calcium intake and recommend physical activity. Patients with rapid weight gain after starting steroids are at greater risk for vertebral compression fractures.

“If you have a patient with bone fragility, you really want to collaborate with your endocrine colleagues,” Dr. Burnham said. Patients who are obese may need nutrition counseling or physical therapy to help them improve and lower their fracture risks.


Susan Bernstein is a freelance medical journalist based in Atlanta.

Second Chance

If you missed this session, it’s not too late. Catch it on SessionSelect.

Pages: 1 2 3 | Multi-Page

Filed Under: Meeting Reports Tagged With: ACR/ARHP Annual Meeting, Bernstein, Children, Fractures, glucocorticoid, Glucocorticoid-Induced Osteoporosis, Osteoporosis, patient care, Pediatric, Rheumatic Disease, therapyIssue: April 2015

You Might Also Like:
  • 2014 ACR/ARHP Annual Meeting: Rheumatologic Research Uncovers Clues to Therapies
  • Bone Density Concerns: Guidance on Tackling Fracture Risk in CKD
  • ACR/ARHP Annual Meeting 2012: New Treatments and Strategies Emerge for Osteoporosis
  • Baseline Bone Measures Predict Risk of Fragility Fracture in Postmenopausal

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.